JAN on watch for bullish continuation LONGJAN had earnings but I cannot find the report. It is trading with heavy volume and it shows in
the price action. Price has pulled back in the after-market in a standard Fibonacci retracement.
A pullback is appropriate here as price has gained 250% in a month. I see the pullback
as healthy and JAN is now well positioned for another bullish continuation. Volatility
and volume supports the conclusion. I will set a stop loss at 10% and targets at 50%, 75% and
100% to take partial profits on an anticipated trend up. Alerts will be set onto a set of
moving averages on the 30 minute time frame to detect death cross unders. Once profit is
hits 10% I will change the stop loss to a trailing 10% stop loss and once above 75% make the
trailing loss 5% and once over 100% change it to 3% so I can let the trade run itself from
those orders.
Lowbeta
ITA - Defense ET
Broke out of falling wedge around 109 and is moving well in the supply zone.
With two wars, geopolitical risks are high and this could play out as a good hedge.
First target would be around 117. New pivot there might set this up for higher price.
I am long from 109.50
GILD - Setting up for multi year run
Monthly chart is setting up nicely.
if it takes out 88, ATH should be quick.
stop loss: 79
ABT a slow moving low beta medical stockABT is Abbott Labs, a well-established medical technology company has had good earnings
twice this year. In the first episode, the price trended down then recovered in a retracement.
I have anchored a long-term mean VWAP and its standard deviations as a means to assess
areas of dynamic support and resistance. One week ago, the price crossed the mean VWAP in
its uptrend. I see this as a good place for a long trade over a month or more. For a stop loss
I will place the stop below the mean VWAP also confluent with two horizontal support lines
as well as the rising support trendline and the POC line of the volume profile
Targets are the first and second standard deviations at about $105 and $110. I will make an
optimal entry from a pivot low on a timeframe of 30-90 minutes.
As the anticipated ROI is relatively small although with reasonable risk, my approach is
a call option for mid-September with a strike in the range of $100-104. I expect this to
yield 25% or more monthly until signs of a pullback or reversal. While the general market
has heightened volatility and controlled chaos, I see adding some trades of slow-moving
low beta stocks to be proper risk management.
Pure Value & Low Beta vs. Pure Growth & High Beta Pure Value & Low Vol relative to Pure Growth & High Beta. The rotation away from duration and beta has been very strong the past 2 months. As QT begins and liquidity dries up even more, I’d continue to favor shorter duration & lower beta segments of the market.
Buy UnileverUnilever has formed a small base on the daily chart inline with major support. There is also bullish divergence on the RSI and we believe scope for a bounce towards 3400p in the short term.
We could see this grind towards the target over the Christmas period.
